MaryAnn Chapman - Publications

Affiliations: 
Visage Comm, Vallejo, CA, United States 
Area:
scientific writing

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Chapman MA, Roll JM, Park S, Galloway MP. Extracellular glutamate decrease in accumbens following cued food delivery. Neuroreport. 14: 991-4. PMID 12802189 DOI: 10.1097/01.Wnr.0000068556.33086.17  0.535
2001 Grimm JW, Chapman MA, Zahm DS, See RE. Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats. Synapse (New York, N.Y.). 39: 51-7. PMID 11071709 DOI: 10.1002/1098-2396(20010101)39:1<51::Aid-Syn7>3.0.Co;2-Z  0.665
1996 Chapman MA, See RE. The neurotensin receptor antagonist SR 48692 decreases extracellular striatal GABA in rats. Brain Research. 729: 124-6. PMID 8874884 DOI: 10.1016/S0006-8993(96)00407-6  0.559
1996 Chapman MA, See RE. Differential effects of unique profile antipsychotic drugs on extracellular amino acids in the ventral pallidum and globus pallidus of rats. The Journal of Pharmacology and Experimental Therapeutics. 277: 1586-94. PMID 8667227  0.555
1994 See RE, Chapman MA. The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals. Critical Reviews in Neurobiology. 8: 85-124. PMID 7907282  0.54
1994 See RE, Chapman MA. Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. European Journal of Pharmacology. 263: 269-76. PMID 7843264 DOI: 10.1016/0014-2999(94)90722-6  0.576
1992 Chapman MA, See RE, Bissette G. Neurotensin increases extracellular striatal dopamine levels in vivo. Neuropeptides. 22: 175-83. PMID 1436404 DOI: 10.1016/0143-4179(92)90160-X  0.595
1992 See RE, Chapman MA, Murray CE, Aravagiri M. Regional differences in chronic neuroleptic effects on extracellular dopamine activity. Brain Research Bulletin. 29: 473-8. PMID 1382815 DOI: 10.1016/0361-9230(92)90085-C  0.6
1992 See RE, Adams-Curtis L, Chapman MA. Assessment of dopamine release by in vivo microdialysis in the nucleus accumbens of rats following acute and chronic administration of desipramine. Annals of the New York Academy of Sciences. 654: 522-4. PMID 1378710 DOI: 10.1111/J.1749-6632.1992.Tb26019.X  0.589
1992 See RE, Chapman MA, Meshul CK. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse (New York, N.Y.). 12: 147-54. PMID 1362290 DOI: 10.1002/syn.890120208  0.605
1992 See RE, Chapman MA, Klitenick MA. Chronic neuroleptic administration decreases extracellular GABA in the nucleus accumbens but not in the caudate-putamen of rats. Brain Research. 588: 177-80. PMID 1356587 DOI: 10.1016/0006-8993(92)91361-H  0.578
1991 See RE, Chapman MA. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats. Pharmacology, Biochemistry, and Behavior. 39: 49-54. PMID 1924511 DOI: 10.1016/0091-3057(91)90396-J  0.565
1991 See RE, Sorg BA, Chapman MA, Kalivas PW. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology. 30: 1269-74. PMID 1686300 DOI: 10.1016/0028-3908(91)90022-4  0.565
Show low-probability matches.